We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
For investors seeking momentum, Invesco DWA SmallCap Momentum ETF (DWAS - Free Report) is probably on radar. The fund just hit a 52-week high and is up 118% from its 52-week low of $32.00 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
DWAS in Focus
This fund offers exposure to the small-cap segment of the broad U.S. stock market with positive relative strength characteristics. It has key holdings in healthcare, consumer discretionary, industrials and information technology. The ETF charges 60 basis points in annual fees (see: all the Small-Cap Blend ETFs here).
Why the Move?
The small-cap corner of the broad U.S. stock market has been an area to watch lately given a vaccine development, which is being viewed as “a beginning to the end” of the coronavirus pandemic. Latest data suggests that a COVID-19 vaccine would be available before the end of this year based on promising trial results released by Pfizer (PFE - Free Report) , Moderna (MRNA - Free Report) and AstraZeneca (AZN - Free Report) . Additionally, improving prospect for a smooth transition of president-elect Joe Biden to the White House led to the strength.
More Gains Ahead?
It seems that DWAS might remain strong given a high weighted alpha of 40.20 and a low 20-day volatility of 27.82%. As a result, there is definitely still some promise for risk-aggressive investors who want to ride on this surging ETF.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Small-Cap ETF (DWAS) Hits New 52-Week High
For investors seeking momentum, Invesco DWA SmallCap Momentum ETF (DWAS - Free Report) is probably on radar. The fund just hit a 52-week high and is up 118% from its 52-week low of $32.00 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
DWAS in Focus
This fund offers exposure to the small-cap segment of the broad U.S. stock market with positive relative strength characteristics. It has key holdings in healthcare, consumer discretionary, industrials and information technology. The ETF charges 60 basis points in annual fees (see: all the Small-Cap Blend ETFs here).
Why the Move?
The small-cap corner of the broad U.S. stock market has been an area to watch lately given a vaccine development, which is being viewed as “a beginning to the end” of the coronavirus pandemic. Latest data suggests that a COVID-19 vaccine would be available before the end of this year based on promising trial results released by Pfizer (PFE - Free Report) , Moderna (MRNA - Free Report) and AstraZeneca (AZN - Free Report) . Additionally, improving prospect for a smooth transition of president-elect Joe Biden to the White House led to the strength.
More Gains Ahead?
It seems that DWAS might remain strong given a high weighted alpha of 40.20 and a low 20-day volatility of 27.82%. As a result, there is definitely still some promise for risk-aggressive investors who want to ride on this surging ETF.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>